The role of AXL signaling in progression and metastasis of pancreatic cancer was confirmed in a study using low-dose warfarin, a vitamin K “antagonist” to inhibit Gas6-dependent AXL activation (72). The gene discussed is AXL; the disease is pancreatic neoplasm.